StonvexLoading…
StonvexStonvexStonvexCore line items from DFNS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2024 2024-06-30 | Q2 2023 2023-06-30 |
|---|---|---|
Revenue | $5.68M | $16.22M |
Operating Income | $-3.11M | $-3.16M |
Net Income | $-1.62M | $-3.15M |
EPS (Diluted) | $-2.31 | $-0.31 |
Total Assets | $1.12M | $4.60M |
Total Liabilities | $13.35M | $4.51M |
Cash & Equivalents | $6.14K | $142.34K |
Free Cash Flow OCF − CapEx | Not available | Not available |
Shares Outstanding | 14.80M | 1.51M |